A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 4530893)

Published in PLoS One on August 10, 2015

Authors

Harry Tagbor1, Matthew Cairns2, Kalifa Bojang3, Sheick Oumar Coulibaly4, Kassoum Kayentao5, John Williams6, Ismaela Abubakar3, Francis Akor3, Khalifa Mohammed3, Richard Bationo4, Edgar Dabira4, Alamissa Soulama4, Moussa Djimdé5, Etienne Guirou5, Timothy Awine6, Stephen Quaye6, Fanta Njie3, Jaume Ordi7, Ogobara Doumbo5, Abraham Hodgson6, Abraham Oduro6, Steven Meshnick8, Steve Taylor9, Pascal Magnussen10, Feiko ter Kuile11, Arouna Woukeu2, Paul Milligan2, Daniel Chandramohan2, Brian Greenwood2

Author Affiliations

1: London School of Hygiene & Tropical Medicine, London, United Kingdom; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
2: London School of Hygiene & Tropical Medicine, London, United Kingdom.
3: Medical Research Council Unit, Fajara, The Gambia.
4: Faculty of Health Sciences, University of Ouagadougou, Ouagadougou, Burkina Faso.
5: Malaria Research and Training Centre, Faculty of Medicine and Odonto-stomatology, University of Sciences, Technics and Technologies, Bamako, Mali.
6: Navrongo Health Research Centre, Navrongo, Ghana.
7: Barcelona Centre for International Health Research (CRESIB), Department of Pathology, Hospital Clinic-Universitat de Barcelona, Barcelona, Spain.
8: Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, United States of America.
9: Duke University Medical Center, Durham, NC, United States of America.
10: (Institute of International Health, Immunology and Microbiology and Institute of Veterinary Disease Biology, University of Copenhagen, Copenhagen, Denmark.
11: Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Associated clinical trials:

Intermittent Preventive Treatment Versus Scheduled Screening and Treatment of Malaria in Pregnancy (IPTp_IST) | NCT01084213

Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa | NCT01103063

Articles citing this

Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial. Lancet (2015) 2.19

Prevalence of malaria infection in pregnant women compared with children for tracking malaria transmission in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health (2015) 1.49

Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial. PLoS Med (2016) 0.94

The Performance of a Rapid Diagnostic Test in Detecting Malaria Infection in Pregnant Women and the Impact of Missed Infections. Clin Infect Dis (2015) 0.86

User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya. PLoS One (2016) 0.85

Non-falciparum malaria infections in pregnant women in West Africa. Malar J (2016) 0.82

Towards a strategy for malaria in pregnancy in Afghanistan: analysis of clinical realities and women's perceptions of malaria and anaemia. Malar J (2015) 0.77

'Some anti-malarials are too strong for your body, they will harm you.' Socio-cultural factors influencing pregnant women's adherence to anti-malarial treatment in rural Gambia. Malar J (2016) 0.76

Spatial heterogeneity can undermine the effectiveness of country-wide test and treat policy for malaria: a case study from Burkina Faso. Malar J (2016) 0.75

Cost effectiveness of intermittent screening followed by treatment versus intermittent preventive treatment during pregnancy in West Africa: analysis and modelling of results from a non-inferiority trial. Malar J (2016) 0.75

The risk of malaria in Ghanaian infants born to women managed in pregnancy with intermittent screening and treatment for malaria or intermittent preventive treatment with sulfadoxine/pyrimethamine. Malar J (2016) 0.75

Articles cited by this

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA (2006) 11.87

Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA (2007) 4.47

Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa. Lancet Infect Dis (2012) 4.15

Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc Natl Acad Sci U S A (2009) 3.30

Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009-11. Lancet Infect Dis (2013) 2.79

Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infect Dis (2011) 2.56

Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA (2013) 2.51

Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial. PLoS One (2010) 2.03

Through the looking glass: understanding non-inferiority. Trials (2011) 1.87

Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations. Malar J (2010) 1.77

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial. PLoS Med (2014) 1.64

Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria. Trends Parasitol (2013) 1.61

Following the path of most resistance: dhps K540E dispersal in African Plasmodium falciparum. Trends Parasitol (2010) 1.53

Active-control trials with binary data: a comparison of methods for testing superiority or non-inferiority using the odds ratio. Stat Med (2008) 1.43

Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi. J Infect Dis (2013) 1.39

Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine. Malar J (2011) 1.38

Plasmodium falciparum mutant haplotype infection during pregnancy associated with reduced birthweight, Tanzania. Emerg Infect Dis (2013) 1.26

Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: provider knowledge and acceptability. PLoS One (2011) 1.17

Pooled deep sequencing of Plasmodium falciparum isolates: an efficient and scalable tool to quantify prevailing malaria drug-resistance genotypes. J Infect Dis (2013) 1.15

A systematic review of the impact of malaria prevention in pregnancy on low birth weight and maternal anemia. Int J Gynaecol Obstet (2013) 1.14

Intermittent preventive therapy with sulfadoxine-pyrimethamine for malaria in pregnancy: a cross-sectional study from Tororo, Uganda. PLoS One (2013) 1.10

Ultrasound-derived fetal size nomogram for a sub-Saharan African population: a longitudinal study. Ultrasound Obstet Gynecol (2009) 1.03

Intermittent preventive treatment in pregnant women is associated with increased risk of severe malaria in their offspring. PLoS One (2013) 1.01

Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study. Malar J (2014) 0.98

Sulfadoxine-pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC). Trop Med Int Health (2011) 0.89

A simple approach to the estimation of incidence rate difference. Am J Epidemiol (2010) 0.88

Articles by these authors

A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt. PLoS One (2016) 1.39

Nesting doctoral students in collaborative North-South partnerships for health systems research. Glob Health Action (2014) 1.05

Informed consent comprehension in African research settings. Trop Med Int Health (2014) 0.98

Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations. Mol Ther (2014) 0.96

Has Tanzania embraced the green leaf? Results from outlet and household surveys before and after implementation of the Affordable Medicines Facility-malaria. PLoS One (2014) 0.91

Impact of an electronic clinical decision support system on workflow in antenatal care: the QUALMAT eCDSS in rural health care facilities in Ghana and Tanzania. Glob Health Action (2015) 0.88

Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso. Antimicrob Agents Chemother (2015) 0.87

Does the National Health Insurance Scheme in Ghana reduce household cost of treating malaria in the Kassena-Nankana districts? Glob Health Action (2014) 0.87

Emergence of a new epidemic Neisseria meningitidis serogroup A Clone in the African meningitis belt: high-resolution picture of genomic changes that mediate immune evasion. MBio (2014) 0.86

Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial. PLoS Med (2016) 0.85

Costs associated with implementation of computer-assisted clinical decision support system for antenatal and delivery care: case study of Kassena-Nankana district of northern Ghana. PLoS One (2014) 0.85

Effects of an adolescent sexual and reproductive health intervention on health service usage by young people in northern Ghana: a community-randomised trial. PLoS One (2015) 0.84

Digitised audio questionnaire for assessment of informed consent comprehension in a low-literacy African research population: development and psychometric evaluation. BMJ Open (2014) 0.83

Socio-demographic and environmental determinants of infectious disease morbidity in children under 5 years in Ghana. Glob Health Action (2015) 0.81

Cost-effectiveness of clinical decision support system in improving maternal health care in Ghana. PLoS One (2015) 0.80

Verbal Autopsy: Evaluation of Methods to Certify Causes of Death in Uganda. PLoS One (2015) 0.80

Quality of antenatal and childbirth care in rural health facilities in Burkina Faso, Ghana and Tanzania: an intervention study. Trop Med Int Health (2015) 0.78

The Evolving Demographic and Health Transition in Four Low- and Middle-Income Countries: Evidence from Four Sites in the INDEPTH Network of Longitudinal Health and Demographic Surveillance Systems. PLoS One (2016) 0.77

Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants. Mol Ther (2016) 0.77

Cost effectiveness of intermittent screening followed by treatment versus intermittent preventive treatment during pregnancy in West Africa: analysis and modelling of results from a non-inferiority trial. Malar J (2016) 0.75

Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants. Mol Ther (2017) 0.75

Multi-Country Evaluation of Safety of Dihydroartemisinin/Piperaquine Post-Licensure in African Public Hospitals with Electrocardiograms. PLoS One (2016) 0.75

Investigation of correlates of protection against pharyngeal carriage of Neisseria meningitidis genogroups W and Y in the African meningitis belt. PLoS One (2017) 0.75

Seasonal Dynamics of Malaria in Pregnancy in West Africa: Evidence for Carriage of Infections Acquired Before Pregnancy Until First Contact with Antenatal Care. Am J Trop Med Hyg (2017) 0.75

Stark Regional and Sex Differences in the Prevalence and Awareness of Hypertension: An H3Africa AWI-Gen Study Across 6 Sites in Sub-Saharan Africa. Glob Heart (2017) 0.75

Emergence and genomic diversification of a virulent serogroup W:ST-2881(CC175) Neisseria meningitidis clone in the African meningitis belt. Microb Genom (2017) 0.75